Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

Takayasu, left, receives the winner's certificate as champion of the one-day Japan Grand Sumo Tournament at Ryogoku Kokugikan arena in Tokyo on Feb. 9, 2025. (Kyodo) TOKYO (Kyodo) -- Former ozeki ...

Nanoscope Therapeutics has reported data from a mid-stage clinical trial that suggests its optogenetic therapy based on light-sensitive molecules is an effective treatment for incurable eye ...

Takayasu arteritis (TAK) is a form of large vessel vasculitis resulting in thickening and stenosis of the large-sized arteries, particularly the aorta and its main branches. Ulcerative colitis (UC) is ...

Former ozeki Takayasu overcame new yokozuna Hoshoryu in the quarterfinals on his way to winning the one-day Japan Grand Sumo Tournament on Sunday. The rank-and-file wrestler defeated sekiwake ...

High dose glucocorticoid therapy (40–60 mg/day prednisone-equivalent) should be initiated immediately for induction of remission in active giant cell arteritis (GCA) or Takayasu arteritis (TAK). We ...